Skip to content

Study · Not a test of the peptide alone · 1992

1 result

Primary structure of thymosin beta 12, a new member of the beta-thymosin family isolated from perch liver.

Low TL, Liu DT, Jou JH

Archives of biochemistry and biophysics1 Feb 1992Cited by 16 (Europe PMC)

PMID1731637 (opens in a new tab)DOI10.1016/0003-9861(92)90361-y (opens in a new tab)PepBankPUB-01731637
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01Computer modelNot a test of Thymosin beta-4 (human) aloneIn silicoOther

    Sequence analysis shows that thymosin beta 12 from perch liver is 79% homologous to thymosin beta‑4.

    In plain wordsA sequence comparison shows that the new perch peptide thymosin beta 12 is 79% similar to thymosin beta‑4.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableSequence homology of thymosin beta 12 with thymosin beta 4
    Study

    n: not reported in source

    Sequence analysis
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Measurements

    sequence homology
    79%
    thymosin beta 12 vs thymosin beta 4

    Source sentences

    Summary
    Sequence analysis reveals that thymosin beta 12 is 79% homologous to thymosin beta 4, an immunomodulator which was originally isolated from calf thymus.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.